Cosmetic
Tel: 0086 571 87206574
Email: service@cirs-group.com
Asia Pacific
China
China Cosmetic Registration and Filing
China New Cosmetic Ingredient Registration and Filing
China Disinfectant Notification
China Cosmetic Ingredient Quality and Safety Information Code Application
China Cosmetics Safety and Efficacy Test
China Cosmetic Safety Assessment Report
China Cosmetic Formula/Label/Claim Review
China Toothpaste Filing
South Korea
Cosmetics Notification in South Korea
Quasi-drug Products Registration in South Korea
Functional Cosmetics Notification in South Korea
Cosmetic GMP Consulting
Japan
ASEAN
Europe
European Union
Compliance with the EU Cosmetic Regulation
Claims and Warnings in the EU and the UK Cosmetic Regulations: A Comprehensive Guide to Compliance
Understanding Labeling Requirements for Cosmetics in the EU and the UK
How to Assess Product Safety according to EU and UK Cosmetic Regulations (CPSR)
Product Information File (PIF)
Responsible Person
United Kingdom
This article compiles and summarizes the latest developments in cosmetics regulations in China and globally as of May 2025, covering industry news, newly issued regulations, relevant policy adjustments, and regulatory requirements. It aims to assist enterprises in ensuring compliance and keeping up with global cosmetics regulatory trends.
In order to strengthen cosmetic regulation and safeguard consumer rights, the NMPA's Department of Cosmetics Supervision has provided answers to key industry concerns-such as labeling-based on current Chinese laws and technical standards. CIRS Group has compiled the information and translated them into English for your reference.
FAQs from Beijing Cosmetics Review and Inspection Center on Ordinary Cosmetics Filing (Vol. 42)
2025-06-16
Following FAQs are all related to cosmetic safety assessment, CIRS Group has compiled the information and translated them into English for your reference.
On 6 June, 2025, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued preliminary opinion (SCCS/1680/25) on Prostaglandin Analogues: Methylamido-Dihydro-Noralfaprostal (MDN) (CAS No. 155206-01-2), Isopropyl Cloprostenate (IPCP) (CAS No. 157283-66-4) and Dechloro Dihydroxy Difluoro Ethylcloprostenolamide (DDDE) (CAS No. 1185851-52-8). The deadline for comments is set for 18 August 2025.
Based on data retrieved from China’s National Medical Products Administration (NMPA), Shenzhen Dieckmann Biotechnology Co., Ltd. completed the filing of Ceramide EOS as a new cosmetic ingredient on June 10, 2025. At present, the associated technical specifications have not been made public, and the ingredient has not yet entered the post-filing monitoring period.